Carnegie Investment Counsel’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $337K | Sell |
1,205
-128
| -10% | -$33.6K | 0.01% | 462 |
|
|
2026
Q1 | $356K | Buy |
1,333
+94
| +8% | +$25.5K | 0.01% | 456 |
|
|
2025
Q4 | $311K | Sell |
1,239
-400
| -24% | -$106K | 0.01% | 476 |
|
|
2025
Q3 | $470K | Hold |
1,639
| – | – | 0.01% | 414 |
|
|
2025
Q2 | $430K | Sell |
1,639
-28
| -2% | -$6.82K | 0.01% | 414 |
|
|
2025
Q1 | $373K | Buy |
1,667
+34
| +2% | +$8.25K | 0.01% | 408 |
|
|
2024
Q4 | $374K | Hold |
1,633
| – | – | 0.01% | 377 |
|
|
2024
Q3 | $365K | Hold |
1,633
| – | – | 0.01% | 376 |
|
|
2024
Q2 | $332K | Hold |
1,633
| – | – | 0.01% | 391 |
|
|
2024
Q1 | $357K | Hold |
1,633
| – | – | 0.01% | 403 |
|
|
2023
Q4 | $371K | Sell |
1,633
-10
| -0.6% | -$2.1K | 0.01% | 388 |
|
|
2023
Q3 | $330K | Sell |
1,643
-269
| -14% | -$56.7K | 0.01% | 396 |
|
|
2023
Q2 | $397K | Sell |
1,912
-32
| -2% | -$6.21K | 0.01% | 382 |
|
|
2023
Q1 | $383K | Sell |
1,944
-29
| -1% | -$5.97K | 0.02% | 388 |
|
|
2022
Q4 | $399K | Hold |
1,973
| – | – | 0.02% | 392 |
|
|
2022
Q3 | $347K | Hold |
1,973
| – | – | 0.02% | 383 |
|
|
2022
Q2 | $397K | Hold |
1,973
| – | – | 0.02% | 365 |
|
|
2022
Q1 | $447K | Hold |
1,973
| – | – | 0.02% | 360 |
|
|
2021
Q4 | $533K | Sell |
1,973
-349
| -15% | -$86.4K | 0.02% | 344 |
|
|
2021
Q3 | $561K | Hold |
2,322
| – | – | 0.02% | 308 |
|
|
2021
Q2 | $550K | Sell |
2,322
-134
| -5% | -$30.5K | 0.02% | 317 |
|
|
2021
Q1 | $538K | Buy |
2,456
+693
| +39% | +$139K | 0.02% | 311 |
|
|
2020
Q4 | $308K | Sell |
1,763
-68
| -4% | -$11.7K | 0.01% | 359 |
|
|
2020
Q3 | $296K | Buy |
1,831
+143
| +8% | +$22.7K | 0.02% | 343 |
|
|
2020
Q2 | $241K | Buy |
+1,688
| New | +$234K | 0.01% | 372 |
|
|
2020
Q1 | – | Sell |
-1,571
| Closed | -$228K | – | 415 |
|
|
2019
Q4 | $228K | Hold |
1,571
| – | – | 0.01% | 390 |
|
|
2019
Q3 | $227K | Hold |
1,571
| – | – | 0.01% | 393 |
|
|
2019
Q2 | $233K | Sell |
1,571
-88
| -5% | -$12.3K | 0.02% | 394 |
|
|
2019
Q1 | $218K | Buy |
+1,659
| New | +$204K | 0.02% | 396 |
|
|
2018
Q4 | – | Sell |
-1,659
| Closed | -$234K | – | 388 |
|
|
2018
Q3 | $234K | Sell |
1,659
-116
| -7% | -$17.6K | 0.02% | 320 |
|
|
2018
Q2 | $275K | Sell |
1,775
-437
| -20% | -$66K | 0.02% | 330 |
|
|
2018
Q1 | $334K | Hold |
2,212
| – | – | 0.03% | 293 |
|
|
2017
Q4 | $322K | Hold |
2,212
| – | – | 0.03% | 317 |
|
|
2017
Q3 | $288K | Hold |
2,212
| – | – | 0.03% | 295 |
|
|
2017
Q2 | $304K | Sell |
2,212
-291
| -12% | -$35.6K | 0.04% | 293 |
|
|
2017
Q1 | $305K | Hold |
2,503
| – | – | 0.04% | 286 |
|
|
2016
Q4 | $278K | Buy |
2,503
+117
| +5% | +$13K | 0.04% | 276 |
|
|
2016
Q3 | $279K | Hold |
2,386
| – | – | 0.04% | 263 |
|
|
2016
Q2 | $282K | Hold |
2,386
| – | – | 0.04% | 267 |
|
|
2016
Q1 | $240K | Hold |
2,386
| – | – | 0.04% | 272 |
|
|
2015
Q4 | $230K | Sell |
2,386
-117
| -5% | -$12.1K | 0.04% | 262 |
|
|
2015
Q3 | $259K | Hold |
2,503
| – | – | 0.04% | 250 |
|
|
2015
Q2 | $261K | Hold |
2,503
| – | – | 0.05% | 250 |
|
|
2015
Q1 | $268K | Hold |
2,503
| – | – | 0.05% | 251 |
|
|
2014
Q4 | $248K | Buy |
2,503
+175
| +8% | +$15.5K | 0.05% | 251 |
|
|
2014
Q3 | $204K | Sell |
2,328
-87
| -4% | -$7.86K | 0.04% | 281 |
|
|
2014
Q2 | $212K | Hold |
2,415
| – | – | 0.05% | 220 |
|
|
2014
Q1 | $204K | Buy |
+2,415
| New | +$193K | 0.05% | 207 |
|
|
2013
Q4 | – | Sell |
-2,415
| Closed | -$206K | – | 213 |
|
|
2013
Q3 | $206K | Hold |
2,415
| – | – | 0.06% | 197 |
|
|
2013
Q2 | $208K | Buy |
+2,415
| New | +$200K | 0.07% | 186 |
|
Other funds holding LH
Carnegie Investment Counsel's LH Position: Q2 2026 in Review
Carnegie Investment Counsel reduced its Labcorp (LH) stake by 9.6% in Q2 2026, selling an estimated $33.6K and leaving 1,205 shares worth $337K. The position accounts for 0.01% of the portfolio, ranked #462.
Carnegie Investment Counsel first reported a position in LH in Q2 2013 and has held it in 50 quarters since. The position peaked at $561K in Q3 2021. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Carnegie Investment Counsel held 1,205 shares of Labcorp worth $337K as of Q2 2026.
- Carnegie Investment Counsel sold 128 Labcorp shares in Q2 2026, an estimated $33.6K.
- Labcorp made up 0.01% of Carnegie Investment Counsel's portfolio in Q2 2026, its #462 holding.
- Carnegie Investment Counsel first reported a position in Labcorp in Q2 2013 and has held it in 50 quarters since.
- Carnegie Investment Counsel's Labcorp position peaked at $561K in Q3 2021.
- 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.